Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
23.60
-0.42 (-1.75%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.74 billion as of March 24, 2026. Its market cap has increased by 108.47% in one year.
Market Cap
1.74B
Enterprise Value
1.49B
1-Year Change
108.47%
Ranking
Category
Stock Price
$23.60
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.74B, an increase of 428.38%. That is a compound annual growth rate of 20.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 1.77B | -10.09% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 1.85B |
| Mesoblast | 1.85B |
| AnaptysBio | 1.81B |
| Ultragenyx Pharmaceutical | 1.79B |
| Definium Therapeutics | 1.77B |
| Ocular Therapeutix | 1.77B |
| Relay Therapeutics | 1.69B |
| Vericel | 1.68B |